Abstract. The aim of this study was to determine whether o-chlorobenzylidene malononitrile (CS) exhibits any genotoxic activity towards Salmonella or mammalian DNA in vivo. CS was synthesized with a [14C]-label at the benzylic carbon atom. It was administered i.p. at a dose level of 13 mg/kg (1 mCi/kg) to young adult male rats. Liver and kidney DNA was isolated after 8, 25, and 75 h. The radioactivity was at (liver, 8 and 75 h) or below (all other samples) the limit of detection of 3 dpm. Therefore, a possible binding of CS to DNA is at least 105 times lower than that of the strong hepatocarcinogen aflatoxin B1, and 4,000 times lower than that of vinyl chloride. In contrast to this lack of DNA binding, but in agreement with the chemical reactivity of CS, a binding to nuclear proteins could be detected with specific activities ranging between 50 and 121 dpm/mg for liver and between 3 and 41 dpm/mg for kidney. Protein binding could well be responsible for its pronounced cytotoxic effects. CS was also tested in the Ames Salmonella/microsome assay. Strains TA 1535, TA 1537, TA 1538, TA 98, and TA 100 were used with or without pre-incubation. Only with strain TA 100 and only without pre-incubation, a doubling of the number of revertants was detectable at the highest dose levels used, 1,000 and 2,000 ~tg CS per plate. With pre-incubation of TA 100 with CS, a slight increase of the number of revertants was seen at 100 and 500 ~tg per plate, and a subsequent fall below control values at 1,000 ~tg. A check for the number of surviving bacteria revealed a strong bacteriotoxicity of the higher doses of CS so that the calculated mutation frequencies, i.e., the number of revertants per number of surviving bacteria, increased with doses up to 500 ~tg. This toxicity could be counteracted in part by the addition of increasing amounts of rat liver microsomes. In the view of these results, and taking into account the rare and low exposure of man, it is concluded that CS will not create a risk for the induction of point mutations or of carcinogenic processes mediated by DNA binding.
Introduction
o-Chlorobenzylidene malononitrile (CS) is a lacrimating riot control agent used in the form of an aerosol or smoke. Its acute toxicity has been studied in various animal species (Gaskins et al. 1972; Ballantyne and Swanston 1978; Cucinell et al. 1971 ), but a possible carcinogenic effect was merely discussed (Schrempf 1978; Anon 1973; Jones 1973; Sanford 1976) . In one report which is not easily available, an inhalation study with a 2-year-period of observation is described: either 100 (50 males and 50 females) A/J strain mice or 100 Sprague-Dawley-Wistar rats were exposed to 21 mg/m 3 aerolized CS for 2.5 or 25 min daily for 20 days (5 days a week for 4 weeks). After 6, 12, 18, and 24 months, groups of animals were sacrificed and examined for lung tumors grossly and microscopically. No significant increase was observed (McNamara et al. 1973 ). However, CS was found to be active in suppressing non-specific esterase activity in mouse skin sebaceous gland (Barry et al. 1972) . This assay was introduced as a screening test for carcinogenicity. Although this test is not generally accepted due to the lack of a sufficient theoretical base and incomplete validation (Purchase et al. 1976) , these controversial findings with CS call for further investigations on putative carcinogenic activity.
There is much evidence that covalent binding of a chemical to DNA is the first step in the induction of a tumor by a genotoxic agent, and a useful quantitative correlation between carcinogenic potency and in vivo DNA binding could be shown for hepatocarcinogens and liver DNA (Lutz 1979) as well as for non-selected tissues (Lutz 1981) .
i cN ~ CH~C~cN CS, as an activated olefin, reacts preferably with SH-groups of proteins (Cucinell et al. 1971) . It also reacts with amino groups such as in lysine (Jones 1972) and it cannot be excluded that it may also react with DNA. In 5% aqueous ethanol, CS is hydrolysed to o-chlorobenzaldehyde and malononitrile with a half life of about 12 min at 25 ~ C (unpublished results). The aldehyde by itself could in principle also react with biological macromolecules, but no data are available to indicate such activity. Besides, no other metabolites are suspected of undergoing a covalent interaction with macromolecules.
In an attempt to detect covalent interactions of CS or its metabolites in vivo, we administered [14C]-labelled CS to rats, isolated nuclei from various organs and measured the radioactivity on nuclear protein or DNA. The radiolabel was introduced into the benzylic carbon atom (denoted with * in the structural formula), so that the electrophilic aldehyde metabolite was still radioactive.
In addition, we performed the Salmonella/microsome assay according to Ames et al. (1975) with and without pre-incubation (Nagao et al. 1977) , in order to obtain, in microorganisms, additional information on possible DNA alterations by CS.
Materials and Methods
Chemicals and General Methods. o-Chloroiodobenzene was purchased from Eastman Kodak, Rochester, NY, USA, hydroxyapatite (DNA-grade Bio Gel HTP) from Bio-Rad, Richmond, CA, USA, sodium dodecylsulfate (SDS) from Sigma, St. Louis, MO, USA, nutrient broth and bacto-agar from Difco, Detroit, MI, USA, aroclor 1254 from Analabs, Inc., North Haven, CT, USA. Silicagel 60 with a particle size 0.063-0.2 mm was from Merck, Darmstadt, FRG, who also supplied all standard reagents of the highest purity available.
[14C]-labelled sodium carbonate (50 mCi) with a specific activity of 57.5 mCi/mMol was purchased from the Radiochemical Centre, Amersham, England. It was diluted with 300 mg inactive Na2CO3 to a specific activity of 14 mCi/mMol.
Radioactivity measurements were carried out in Insta-Gel (Packard Instruments, Downers Grove, IL, USA) in a liquid scintillation counter, Packard Tri Carb 460 CD.
Synthesis of o-Chloro-[14C]Benzylidene Malononitrile. The [14C]-CS was synthesized with a
[14C]-label at the benzylic carbon atom according to Harrison et al. (1978) . o-Chloroiodobenzene was first converted in a Grignard reaction to o-chlorobenzene magnesium iodide, and 50 mCi [14C]O2, generated by concentrated sulfuric acid from Na2114C]O3 was used to produce o-chloro [laC] immediately before administration. In this solvent and within this short time, CS is chemically stable as checked by thin-layer chromatography. The total radioactivity administered was in the range of 0.85-1.14 mCi/kg body weight, corresponding to 11-15 mg CS/kg, which is about a quarter of the LDs0 i.p. for male rats (Ballantyne and Swanston 1978) . The animals were kept individually in metabolism cages for collection of urine. At 8, 25, and 75 h after the injection, two animals were killed by open heart puncture under ether anaesthesia. Liver and kidney were excised and cell nuclei were prepared immediately.
Preparation of Nuclei. Nuclei of liver and both kidneys were isolated in the cold according to Viviani et al. (1978) , with some modifications. The organs were washed in 0.25 M sucrose-TKM (50 mM Tris-HC1, pH 7.5, 2.5 mM KCI, 5 mM MgCI2). 10 g liver and about 1.5 g kidney were homogenized, respectively, in 30 ml and 12 rnl 0.25 M sucrose-TKM in a loose fitting Potter-Elvehjem type homogenizer with 10 up-and-down strokes at 500 rpm. The homogenates were spun for 20 min at 2,000 g, the pellets were resuspended in 30 ml and 12 ml 0.25 M sucrose-TKM and centrifuged for 5 min at 1,000 g. The resulting pellets were finally resuspended in 30 ml and 15 ml 2.2 M sucrose-TKM. 1.5 ml of 2.3 M sucrose-TKM was underlayered and the tube centrifuged for 20 min at 80,000 g in a Sorvall AH-627 swinging bucket rotor to spin down the nuclei.
Isolation and Purification of DNA from Nuclei. DNA was isolated from the nuclei according to procedure 1 of Markov and Ivanov (1974) . One half to 1 mg purified DNA was obtained per g organ. DNA was dissolved in 4 ml of 0.014 M sodium phosphate buffer, pH 6.8, and the concentration was determined on the basis of a UV absorbance of 20 at 260 nm for a solution of 1 mg/ml. A maximal contamination with 0.1% nuclear protein was determined from control experiments where the protein was labelled with [35S] after feeding of [35S]methionine and by measuring the specific activity of purified DNA and nuclear protein.
Purification of Nuclear Protein. Nuclear protein was precipitated from the first chloroform : phenol : isoamyl alcohol extract by adding 20 ml acetone and spinning for 5 min at 1,000 g. The pellet was dissolved in 2 ml of 1% SDS, 0.014 M sodium phosphate, pH 6.8, precipitated again with 20 ml acetone and centrifuged. This procedure was repeated once. Dialysis overnight against 1,000 volumes of water and one more precipitation resulted in no further changes in the specific activity of the proteins. The pellets were dissolved in 5 ml 1% SDS, 0.014 M sodium phosphate, pH 6.8. One milliliter was taken for the radioactivity measurement. The amount of protein was measured according to Lowry et al. (1951) . Ames et al. (1975) . Salmonella typhimurium strains TA 1535, TA 1537, TA 1538, TA 98, and TA 100 were obtained from B. N. Ames. The procedure of Ames et al. (1975) was modified in the following steps: To a stationary phase culture of the tester strains which had been checked for the genetic markers according to Ames et al. (1975) , a sterile solution of glycerol was added to give a final concentration of 10% (v/v) . The cultures were stored in aliquots of 0.5 ml at -80 ~ C. These frozen permanents were thawed immediately prior to use, 0.2 ml were inoculated into 10 ml nutrient broth supplemented with 10 ~tg/ml L-histidine-HCl and incubated for 5 h in a shaking water bath (100 cycles/rain; 37 ~ C). The number of living cells in the 5-h-culture was determined by diluting the cell suspension one million fold with 0.85% NaC1 and plating on complete medium (0.8% nutrient broth, 0.5% NaC1, 1.5% Bacto-Agar).
Salmonella/Microsome Mutagenicity Assay According to
Livers of aroclor 1254-induced adult male rats (200 g) were homogenized in three volumes 0.25 M sucrose, 0.01 M Tris-HC1 buffer, pH 7.4. One half milliliter S-9 mix, containing various concentrations of undiluted S-9, was used per plate. CS was dissolved in dimethylsulfoxide and 50 pJ solution was added per plate. Both the plate incorporation assay of Ames et al. (1975) and the pre-incubation method (Nagao et al. 1977) were used. S-9 mix or buffer alone (1.5 ml), cells (0.3 ml), and CS (0.15 ml) were mixed in this order. Upon addition of 500 Ixg CS or more, a white precipitate formed in the cell suspension, indicating the limits of water solubility of CS. Six milliliter soft agar containing 0.05 mM of each biotin and histidine were added directly or after pre-incubation for 20 rnin at 37 ~ C in a shaking water bath. After vigorous mixing, 2.5 ml of the suspension was poured onto each of three replicate plates.
For the determination of possible bactericidal effects of CS, different dilutions of the 5-h-culture with 0.85% NaC1 (102 x-2 9 105 x, depending on the concentration of CS and S-9) were mixed with buffer, test compound and S-9 according to the test protocol for the mutagenicity assays. The cells were suspended in top agar containing 0.05 mM biotin and 60 p.g/ml L-histidine-HC1 to allow also histidine-auxotrophic cells to grow.
As positive controls for the assays without rat liver S-9 added, 2-Nitrofluorene (2-NF, 15 ~tg per plate) was used for strains TA 1538 and TA 98, sodium azide (NAN3; 5 Ixg per plate) for strains TA 1535 and TA 100, and 9-aminoacridine (9-AA; 100 ~tg per plate) with strain TA 1537. For the assays with rat liver S-9 added, 2-aminoanthracene (2-AA; 20 ~tg per plate for the strains TA 1535, TA 1537, 10 ~tg for TA 1538, 5 or 10 Ixg for TA 98, TA 100) was used as a positive control for all strains.
Results

Kinetics.
The administered radioactivity rapidly appeared in the urine of the treated rats. Within 8 h, 75% of the dose was metabolized to water-soluble compounds and excreted, and after 75 h this fraction had increased to 84%. The radioactivity in the organ homogenates, 8 h after the administration, was in the range of 0.07-0.25% of the dose in the liver, and 0.014-0.1% in the kidney. Similar levels were found after 25 h, whereas after 75 h, the corresponding values had decreased to about a third.
Protein Binding. The highest activity of CS bound to nuclear protein was determined to be 121 dpm/mg protein in the liver and 41 dpm/mg in the kidney. Liver-protein binding was highest after 25 h, whereas the specific activity of kidney protein decreased already after 8 h and was at the limit of detection at 75 h (Table 1) .
DNA Binding. In contrast to the findings with protein, a radioactivity just above the limit of detection (liver 8 h and 75 h) or no significant radioactivity at all (all other cases) could be detected on the purified DNA (Table 1) .
Mutagenicity Data. Only with strain TA 100 was a very weak mutagenic effect detectable. As much as 1 or 2 mg CS was needed in order to double the number of revertants in the standard plate assay (Table 2) . Upon pre-incubation, a slight increase of the number of revertants could be detected already with 100 ~tg (Table 3) . This weak mutagenic effect was not seen upon addition of 10% S-9 and an additional series of experiments using also 3% or 30% S-9 revealed that CS can best exert its weak mutagenicity in the absence of S-9, be this without (Fig. 1) or with (Fig. 2 ) pre-incubation: Without pre-incubation (Fig. 1) , there was a linear dose-effect relationship between 500 and 2,000 ~tg per plate. The addition of an S-9 mix containing 3% or 10% S-9 reduced the mutagenic effect while 30% S-9 completely abolished mutagenicity. The higher number of control revertants per plate with increasing S-9 concentrations can be explained by a growth stimulation by traces of histidine present. Pre-incubation with high doses of CS in all strains resulted in a decrease of the number of revertants (Table 3) . This sign of cytotoxic activity of CS is not seen Table. 2. Number of revertants a in the Salmonella/microsome mutagenicity assay induced by CS in various Salmonella strains with (+, 10%) and without (-) o~a metabolic activation with rat liver S-9. Assay without pre-incubation when 10% S-9 was added to the incubation mixture. It is probable that under these conditions CS reacts preferentially with the liver proteins, so that less is available to penetrate the bacterial cell wall. In the more extended studies with TA 100 and varying doses of S-9 (Fig. 2) , a slight increase in the number of revertants resulted already between 10 and 100 ixg CS per plate. This rise was followed by a decrease leading to an approximate 50% reduction of the total (Table  3 , Fig. 2 ) pre-incubation revealed the higher sensitivity of the latter method with respect to the number of revertants but also with respect to the cytotoxicity of the compound under investigation.
In order to find out whether the weak mutagenicity detected in strain TA 100 would be more pronounced if cell survival was accounted for, the number of surviving cells as a function of the dose of CS was determined. Without pre-incubation (Fig. 3) , a decrease to about two thirds in cell survival was observed between 1 and 2 mg CS, a bactericidal effect which could not be counteracted by the addition of increasing concentration of S-9. With pre-incubation (Fig. 4) , the addition of 100 ~tg per plate already strongly reduced cell survival. Here, the toxic effects of CS were partially overcome by the addition of S-9.
The toxic effects of CS were also revealed by the growth inhibition of resistant colonies. After incubation for 2 days at 37 ~ C only small colonies were formed on plates containing 1,000 and 2,000 Ixg CS. Colonies could only be counted after 3 days.
If the mutagenic effects are expressed as mutation frequencies (number of mutants per number of surviving cells) the mutagenic effects of CS increase by a factor of two in the plate incorporation assay as a result of the reduction of cell survival. Upon pre-incubation, this situation seems to be more pronounced and the slight increase in the number of revertants observed in the absence of S-9 (Fig. 4) is taken into account.
Discussion
Our results show that CS can undergo a covalent interaction with rat nuclear protein in liver and kidney in vivo, but no reaction with the DNA of these organs could be measured. CS or its metabolites can therefore reach the nuclei of liver and kidney in a chemical form which is reactive only towards protein but not towards nucleic acid. The ratio of protein binding to DNA binding is more than 100 on a weight basis. This difference might be due to the selectivity of CS to react with an appropriate reacting partner. The double bond of CS is rendered slightly electrophilic because of the strongly electron withdrawing substituents. It therefore seems to react preferentially with SH-groups of protein (Cucinell et al. 1971 ). In addition, the radiolabelled hydrolysis product of CS, o-chloro-benzaldehyde, might have reacted with amino groups of protein. Protein binding is probably responsible for cytotoxic effects of chemicals (Gillette 1974; Reid et al. 1973; Schumann et al. 1980 ) but seems to be less directly involved in the process of tumor induction than is DNA binding (Brookes and Lawley 1964) . For instance, another typical SN2-reactive compound, iodoacetamide, reacts with protein but not with DNA and has never been shown to be carcinogenic (Lawley and Brookes 1968) . Radioactivity on DNA was on a very low level or even below the limit of detection. The calculated Covalent Binding Index (CBI) was at the most 0.16 + 0.12 for liver (75 h) and < 0.85 for kidney (75 h). These values must be compared with that of known carcinogens. The CBI of the strong hepatocarcinogen aflatoxin B1 is approximately 10,000 and that of vinyl chloride, another known carcinogen is around 500. More conspicuously, an equal radioactivity dose administered in the form of vinyl chloride instead of CS would have resulted in a specific activity of 3,600 dpm/mg liver DNA due to covalent binding.
CBI's in the order of i were found for the weakest or suspected carcinogens like benzene (review by Lutz 1979) . The binding of CS, if there is any at all, therefore lies below the region of the weakest initiating carcinogens.
As a first approximation, a Covalent Binding Index is a dose-independent, only compound-related figure. First order kinetics seem to prevail for the binding of genotoxic carcinogens to biological macromolecules in vivo down to very small doses, as was shown with trans-4-dimethylaminostilbene (Neumann 1980) . A linear dose-binding relationship was found down to as little as 25 ng chemical administered per rat.
For the estimation of the quantity of DNA damage, i.e., for an estimation of the risk for cancer, the actual dose has to be taken into account. We estimate a maximal intake of about 1 mg per man after an acute inhalation of air containing 200 mg/m 3, a concentration that may be generated after an attack with an aerosol spray. This is extremely minute as compared with the intake of other toxic substances such as vinyl chloride by polymerization workers, where the daily intake of more than 1 g over several years produced in about 0.2% of these workers a haemangiosarcoma of the liver (Selikoff and Hammond 1975) . This comparison means that not only the DNA-interacting potency of CS is at least three orders of magnitude weaker than that of vinylchloride, but also that the actual exposure differs by many orders of magnitude.
The mutagenicity data suggest that CS can interact with bacterial DNA. As could be expected on the basis of its chemical reactivity, CS is mutagenic without addition of S-9. Only TA 100 yielded a positive response. This strain contains the plasmid pKM 101 which makes it more sensitive as compared with its parent strain TA 1535, an indicator strain for base pair substitutions. Also, large amounts of CS were needed to produce a slight effect, e.g., a 4x enhancement of the spontaneous mutation frequency with 2,000 ~tg CS per plate. CS can therefore be called very weakly mutagenic for Salmonella. In the presence of mammalian cell components, the mutagenic activity vanished. CS was markedly bactericidal. As expected, this toxicity was most pronounced in bacteria pre-incubated with the test compound in the absence of S-9. Addition of increasing amounts of S-9 reduced the bacteriotoxicity, perhaps as the result of a binding of CS to protein, an activity which was also observed in vivo.
The data presented above suggest that CS cannot exhibit a carcinogenic activity induced by DNA binding. Taking also into account the rare and low exposure of humans, the risk for the induction of point mutations and for the carcinogenic process derived thereof must be regarded negligible.
